Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy (SELECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03193437
Recruitment Status : Recruiting
First Posted : June 20, 2017
Last Update Posted : February 18, 2021
Sponsor:
Collaborators:
Hackensack Meridian Health
Karyopharm Therapeutics Inc
Information provided by (Responsible Party):
Georgetown University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021